To access this element change to forms mode OFF
Grant Award View - GA289068
Tailored adjuvant therapy in POLEmut & NSMP early stage endometrial...
GA ID:
GA289068
Agency:
Department of Health and Aged Care
Approval Date:
9-Dec-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 31-Jan-2028
Value (AUD):
$1,398,618.77
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Tailored adjuvant therapy in POLEmut & NSMP early stage endometrial cancer (TAPER)
Purpose:
The number of endometrial (uterine) cancer (EC) cases in Australia is rising rapidly. Research advances mean biological (molecular) markers in tumour samples can identify a specific group of EC patients who will have exceptionally good survival, and who might not need either chemotherapy or radiotherapy after surgery, saving the patient long term side effects and reducing treatment costs overall. This clinical trial will implement molecular testing of EC to avoid unnecessary toxic therapies.
GO ID:
GO Title:
MRFF 2021 Clinical Trials Activity Grant Opportunity
Internal Reference ID:
2022/MRF2022536
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Australia New Zealand Gynaecological Oncology Group
Recipient ABN:
69 138 649 028
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, VIC, SA, WA
Postcode:
Multiple
Country:
AUSTRALIA